Delivery Order SPE2DB22D3016-SPE2DB24FBFE4

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $7,963.28 contract is for the delivery of 4,563,731,858 units of the drug Clobazam 10 mg tablets. The delivery order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,564,802,319 units of the pharmaceutical product Clobazam 10 mg tablets. The fixed-price contract has a ceiling value of $2,403.76 and runs through June 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medical supplies without any set-aside designation. This contract is likely part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,508.28 firm-fixed-price contract is for the delivery of 4,565,281,392 units of the pharmaceutical drug Clobazam 10 mg Tablet, with a completion date of July 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,576.09 firm fixed-price contract is for the delivery of 4,567,750 units of the drug Clobazam 10 mg tablets. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,555.93, is for the delivery of 4,567,841,426 units of the drug Clobazam 10 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement, and the ultimate completion date is April 9, 2025. The contract was awarded on April 8, 2025 and does not have a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,853.88, is for the supply of 4,566,719,361 units of the generic drug Clobazam 10 mg tablets. The contract has a completion date of December 16, 2024 and is a firm fixed-price type. It was not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,935.11 firm fixed-price contract is for the supply of 4,563,131,211 units of the medication clobazam 10 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) to provide 4,563,599,406 units of the pharmaceutical product Clobazam 10 mg Tablet 100s. The potential value of this order is $4,728.08 with a completion date of February 9, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is a prime contractor that provides a wide range of pharmaceutical products and medical supplies...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,955,772 tablets of the medication Clobazam 10 mg, with a total ceiling value of $7,593.04. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 18, 2025. This order is not associated with any set-aside program and was competitively...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,820.13 for the supply of 4,565,563,070 units of the prescription drug Clobazam 10 mg tablet. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 26, 2024. The contract is a firm fixed-price delivery order and does not utilize any set-aside designations. AmerisourceBergen holds a larger Indefinite...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBFE4
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $11,577.14, is for the supply of 4,565,585,943 units of the pharmaceutical drug clobazam 10 mg tablets. The delivery order was awarded on August 26, 2024, with an ultimate completion date of August 27, 2024. This contract is not set aside for any specific business category. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to various federal agencies, including the DLA, through its extensive distribution network. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999 and $750,000, respectively, for the provision of a wide range of medical commodities to support military treatment programs and federal healthcare needs nationwide.

Generated 11/25/24, 9:07 AM